Drug intelligence / Profile preview

calenduloside e

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Calenduloside E is a natural pentacyclic triterpenoid saponin primarily isolated from the root bark of *Aralia elata* (Miq.) Seem. It is characterized by its anti-atherosclerotic and vasoprotective properties, specifically demonstrating the ability to protect human umbilical vein endothelial cells (HUVECs) from injury induced by oxidized low-density lipoprotein (ox-LDL). Its primary mechanism of action involves binding to the Heat shock protein 90 beta (HSP90β) isoform, specifically interacting with the Asp93 residue in the protein's regulatory pocket. Although it shows potential as a therapeutic lead for cardiovascular diseases, its clinical application has been hampered by relatively weak potency and a narrow therapeutic index, leading researchers to develop synthetic derivatives (such as hybridization with ticagrelor fragments) to enhance its binding affinity and efficacy.

Other names
Oleanolic acid 3-O-beta-D-glucuronide3-O-beta-D-glucuronopyranosyloleanolic acidOleanolic acid 3-glucuronide
02

Targets

HSP90AB1 (Heat shock protein HSP 90-beta)

Beyond the preview

Go deeper on calenduloside e.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on calenduloside e.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call